Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





AI-Based Breathalyzer Can Electronically `Smell` Coronavirus and Detect Infection in Under Two Minutes

By LabMedica International staff writers
Posted on 07 Jan 2021
A simple breathalyser test uses artificial intelligence (AI) to electronically "smell' the novel coronavirus and detect infection in less than two minutes.

Scientists at the Gadjah Mada University (Jogjakarta, Indonesia) have developed the GeNose C19 or Gadjah Mada Electronic Nose that rapidly detects COVID-19 using only a person’s breath. More...
The electronic-based diagnostic tool uses the cloud computing system to deliver real-time diagnosis results and can also be run in parallel through a centralized diagnostic process to maintain data validity for all connected devices.

The device uses powerful filters and suction to remove all COVID-19 droplets or particles and sterilize itself for the next test. GeNose C19 offers the advantages of lower cost per test, instant test results, ease of mass production, and high specificity and sensitivity. The Indonesian government has granted a distribution permit for GeNose C19 which is already being used to screen patients for COVID-19 by three hospitals across the country.

"We need faster screening to prevent people getting infected," said Bambang Brodjonegoro, Indonesia's Minister for Research and Technology. "This will accelerate the detection process and mitigate the risk of the pandemic spreading."

Related Links:
Gadjah Mada University


Platinum Member
Fully Automatic ACLIA Analyzer
MAGLUMI X8
Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Automated Urinalysis Solution
UN-9000
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The method combines ultrasonic and fluorescence techniques to track amyloid aggregation in real time (Image Credit: Shutterstock)

Blood Test Measures Amyloid Seeding Activity to Detect Alzheimer’s Disease

Early, accurate diagnosis of Alzheimer’s disease (AD) remains challenging in routine practice, despite its role as the leading cause of dementia worldwide. Confirmation typically relies on cerebrospinal... Read more

Pathology

view channel
Image: TRUECAM automatically eliminates ambiguous or uninformative regions in whole-slide pathology images, enhancing the reliability of diagnostic analysis. (Photo courtesy of PolyU)

AI-Pathologist Framework Improves Accuracy and Reliability in Cancer Diagnosis

Ensuring reliable cancer diagnosis from digital pathology remains a critical challenge as clinical decisions rely on accurate slide interpretation. While artificial intelligence (AI) has accelerated whole-slide... Read more

Industry

view channel
Image: HealthTab will distribute the Abbott Afinion 2 Analyzer to NHS-linked pharmacies for hemoglobin A1c (HbA1c) and lipid profile testing. (Photo courtesy of Abbott)

New Collaboration Expands Point-of-Care Testing Across UK Community Pharmacies

HealthTab, a wholly owned subsidiary of Avricore Health, has entered a formal collaboration agreement with Abbott to supply and distribute Abbott’s point-of-care testing products in the UK through the... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.